40 Equity and ETF Scripts Long Term Growth Portfolio | MarketCap – Mid & Small Cap 400 | Rebalancing Monthly | Equity ETFs Composition is 30% | 12 Months Subscription Plan

₹119,250.00 for 1 year

Telegram Bot Command for @ShubhaangBot : /ms400_40_4770000_e_30

Portfolio Parameters

Parameter	Value
Stock Group Title	MarketCap – Mid & Small Cap 400
Portfolio Size	40 Equity and ETF Scripts {28 Equities and 12 Equity ETFs}
ETFs Composition Percentage	Equity ETFs Composition is 30%
Portfolio Risk	Future Risk may Exceed 40%
Minimum Annual Investment Capital	₹ 47,70,000
Optimal Investment Tenure	8 or more years.
Rebalancing Frequency	Rebalancing Monthly
Subscription Tenure	12 Months Subscription Plan
Backtest – Sharpe Ratio	Hist. Sharpe Ratio above 1.6
Backtest – Annualised Returns	Hist. Annualised Returns Under 50%
Backtest – Annualised Risk	Hist. Annualised Risk Exceeding 20%
Backtest – Max. Drawdown	Hist. Max. Drawdown Exceeding 25%
Backtest – Max. Recovery Time	Hist. Max. Recovery Time Exceeding 9 Quarters
Simulation – Lumpsum Capital Growth Multiple	** More than 181 times in 20 yrs with 99.9% probability

Probability Levels (%)	20 Years	15 Years	10 Years	5 Years	3 Years	1 Year
99.9% Probability	** 181.28	34.31	7.00	1.61	1.01	0.73
99% Probability	397.88	66.68	12.03	2.42	1.37	0.88
98% Probability	527.41	85.51	14.65	2.79	1.52	0.93
95% Probability	805.04	123.89	19.72	3.43	1.79	1.03
90% Probability	1,178.70	171.72	25.75	4.13	2.07	1.11
80% Probability	1,897.32	257.53	35.82	5.20	2.47	1.23
75% Probability	2,294.82	302.67	40.83	5.70	2.65	1.28
50% Probability	7,270.72	789.11	85.40	9.24	3.79	1.56

Refer to the “Backtests & Simulations” tab for further details on their operational settings.

Target high-growth opportunities in mid- and small-cap stocks for aggressive long-term capital appreciation.

Higher Growth Potential: Indian midcap and smallcap stocks are expected to grow at a CAGR of around 13-15%, offering significantly higher returns compared to traditional asset classes like fixed income or large-cap equities.
Untapped Market Opportunities: These stocks represent emerging companies and niche sectors poised for rapid expansion, providing access to innovative and entrepreneurial ventures not available in other asset classes.
Favorable Demographics and Reforms: India’s young population, demographic dividend, and ongoing government reforms support long-term growth prospects for mid and smallcap stocks, making them a compelling choice for investors seeking superior wealth accumulation over the coming decades.

The broad universe for securities comprises of listed companies within the NSE 500 Index and all ETFs, which are meticulously filtered qualitatively in accordance with the predefined investment objective and investment rationale.
Proprietary algorithms, advanced quantitative models, and technical analysis are applied to systematically identify securities with the highest likelihood of delivering superior returns.
These models, extensively validated across various asset classes and time horizons, incorporate customized proprietary indicators of momentum, volume, volatility, and trend, ensuring that portfolio construction is entirely driven by objective data and high-quality signals, free from biases, prejudices, or emotional influence.
The selection of securities and their respective weightings within the model portfolio is further optimized based on factors including the target portfolio size, ETF allocation, average daily trading turnover, available investment capital, rebalancing frequency, as well as the number of quantitative and technical criteria met by each security.

Stocks Group Title	MarketCap – Mid & Small Cap 400
Scripts Types	Equities and Equity ETFs
Portfolio Size	40 Equity and ETF Scripts
ETFs Composition Percentage	Equity ETFs Composition is 30%
Portfolio Risk	Future Risk may Exceed 40%
Ideal Annual Investment	Capital above ₹ 47,00,000
Optimal Investment Tenure	8 or more years
Rebalancing Frequency	Rebalancing Monthly
Subscription Tenure	12 Months Subscription Plan
Subscription Plan Fee	Annual Subscription Fee Under ₹ 1,20,000
Backtest - Sharpe Ratio	Hist. Sharpe Ratio above 1.6
Backtest - Annualised Returns	Hist. Annualised Returns Under 50%
Backtest - Annualised Risk	Hist. Annualised Risk Exceeding 20%
Backtest - Max. DrawDown	Hist. Max. Drawdown Exceeding 25%
Backtest - Max.Recovery Time	Hist. Max. Recovery Time Exceeding 9 Quarters
Simulation Lumpsum Multiple	More than 181 times in 20 yrs with 99.9% probability

Backtest models are constructed using a limited set of assumptions about market conditions and portfolio characteristics; therefore, backtest results should not be interpreted as indicative of actual past performance in real-world conditions.
Backtest results and Simulation results should never be used as a basis for comparing the actual performance of other intermediaries.
Backtest and simulation outputs are provided solely as factual data to support comparative assessment of my subscription plans. They highlight the model’s potential in relation to the portfolio’s investment rationale and parameters under the stated investment methodology.
Simulation results are derived from 100,000 trials and represent potential future scenarios based on normalised inputs (average returns and return volatility) obtained from backtesting.
Users are strongly advised to exercise extreme caution when using this information.
These back-test results and simulation have not been verified by PaRRVA (Past Risk and Return Verification Agency) or any other SEBI-recognized agency.
The impact of periodic portfolio rebalancing and transaction costs has been factored into these back-test results.
"Backtesting and simulation results do not serve as indicators of future performance or guarantees of returns and they should not be interpreted as an endorsement or advertisement."

Monthly Portfolio Returns are assumed to follow a normal distribution over a 20-year horizon, with mean returns and volatility presumed to mirror historically observed levels.
Portfolios are rebalanced once monthly.
Portfolio risk level and Sharpe ratio are assumed to remain unchanged over the 20-year period.
Other than the initial lump sum investment, no additional contributions or withdrawals are made over the 20 years period.
Portfolio rebalancing is assumed to be unconstrained by liquidity over the 20‑year period: required quantities of each security can be bought or sold at competitive prices on every rebalancing, and transaction volumes are assumed to have a negligible impact on market prices.
Earnings from dividends are ignored.
Simulation results are not adjusted for inflation rates.
Effects of taxes on the capital appreciation (Capital Gains Tax & Taxes on Dividends) are not accounted.

Transactional costs are included in the Sharpe ratio calculations.
Risk free rate is assumed to be 6.5% p.a.
Each simulation value is resulted from 1,00,000 simulation trials using the Monte Carlo method.
Simulation results are derived for probability levels (confidence levels) of 99.9%, 99%, 98%, 95% and 90%.
Simulation values do not predict or reflect future market conditions; they represent only possible future outcomes.